Capital Investment Advisors, LLC Eli Lilly & CO Transaction History

Capital Investment Advisors, LLC

  • $4.79 Billion
  • Q3 2024

A detailed history of Capital Investment Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Capital Investment Advisors, LLC holds 25,228 shares of LLY stock, worth $19.8 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
25,228
Previous 25,621 1.53%
Holding current value
$19.8 Million
Previous $23.2 Million 3.65%
% of portfolio
0.47%
Previous 0.53%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024
SELL
$772.14 - $960.02 $303,451 - $377,287
-393 Reduced 1.53%
25,228 $22.4 Million
Q2 2024

Jul 12, 2024
SELL
$724.87 - $909.04 $313,868 - $393,614
-433 Reduced 1.66%
25,621 $23.2 Million
Q1 2024

Apr 15, 2024
SELL
$592.2 - $792.28 $130,284 - $174,301
-220 Reduced 0.84%
26,054 $20.3 Million
Q4 2023

Jan 05, 2024
BUY
$525.19 - $619.13 $14,180 - $16,716
27 Added 0.1%
26,274 $15.3 Million
Q3 2023

Oct 16, 2023
BUY
$434.7 - $599.3 $11.4 Million - $15.7 Million
26,247 New
26,247 $14.1 Million
Q1 2023

Apr 10, 2023
SELL
$310.63 - $364.82 $317,153 - $372,481
-1,021 Reduced 3.57%
27,547 $9.46 Million
Q4 2022

Jan 05, 2023
SELL
$321.55 - $374.67 $286,822 - $334,205
-892 Reduced 3.03%
28,568 $10.5 Million
Q3 2022

Oct 05, 2022
SELL
$296.48 - $337.87 $104,360 - $118,930
-352 Reduced 1.18%
29,460 $9.53 Million
Q2 2022

Jul 06, 2022
SELL
$278.73 - $327.27 $57,975 - $68,072
-208 Reduced 0.69%
29,812 $9.67 Million
Q1 2022

Apr 13, 2022
BUY
$234.69 - $291.66 $53,978 - $67,081
230 Added 0.77%
30,020 $8.6 Million
Q4 2021

Jan 10, 2022
BUY
$224.85 - $279.04 $29,455 - $36,554
131 Added 0.44%
29,790 $8.23 Million
Q3 2021

Oct 13, 2021
SELL
$221.6 - $272.71 $98,612 - $121,355
-445 Reduced 1.48%
29,659 $6.85 Million
Q2 2021

Jul 14, 2021
BUY
$180.55 - $233.54 $177,480 - $229,569
983 Added 3.38%
30,104 $6.91 Million
Q1 2021

Apr 27, 2021
SELL
$164.32 - $212.72 $139,014 - $179,961
-846 Reduced 2.82%
29,121 $5.44 Million
Q4 2020

Jan 21, 2021
SELL
$130.46 - $172.63 $71,883 - $95,119
-551 Reduced 1.81%
29,967 $5.06 Million
Q3 2020

Oct 29, 2020
SELL
$146.22 - $169.13 $7,895 - $9,133
-54 Reduced 0.18%
30,518 $4.52 Million
Q2 2020

Jul 20, 2020
SELL
$136.42 - $164.18 $43,381 - $52,209
-318 Reduced 1.03%
30,572 $5.02 Million
Q1 2020

Apr 13, 2020
SELL
$119.05 - $147.35 $117,383 - $145,287
-986 Reduced 3.09%
30,890 $4.29 Million
Q4 2019

Jan 21, 2020
SELL
$106.92 - $132.43 $8,767 - $10,859
-82 Reduced 0.26%
31,876 $4.19 Million
Q3 2019

Oct 24, 2019
SELL
$106.79 - $116.16 $14,096 - $15,333
-132 Reduced 0.41%
31,958 $3.57 Million
Q2 2019

Jul 17, 2019
SELL
$110.79 - $129.32 $93,174 - $108,758
-841 Reduced 2.55%
32,090 $3.56 Million
Q1 2019

Apr 11, 2019
SELL
$111.31 - $131.02 $100,290 - $118,049
-901 Reduced 2.66%
32,931 $4.27 Million
Q4 2018

Jan 17, 2019
SELL
$105.9 - $118.64 $182,571 - $204,535
-1,724 Reduced 4.85%
33,832 $3.92 Million
Q3 2018

Oct 15, 2018
BUY
$85.86 - $107.31 $173,265 - $216,551
2,018 Added 6.02%
35,556 $3.82 Million
Q2 2018

Jul 10, 2018
SELL
$75.7 - $86.88 $120,287 - $138,052
-1,589 Reduced 4.52%
33,538 $2.86 Million
Q1 2018

Apr 16, 2018
BUY
$74.21 - $87.6 $77,772 - $91,804
1,048 Added 3.08%
35,127 $2.72 Million
Q4 2017

Jan 17, 2018
SELL
$81.94 - $87.89 $27,695 - $29,706
-338 Reduced 0.98%
34,079 $2.88 Million
Q3 2017

Oct 17, 2017
BUY
$77.07 - $85.54 $2.65 Million - $2.94 Million
34,417
34,417 $2.94 Million

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $744B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Capital Investment Advisors, LLC Portfolio

Follow Capital Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email